NASDAQ:CYCU Cycurion Q1 2025 Earnings Results & Report $2.49 -0.13 (-4.96%) Closing price 04:00 PM EasternExtended Trading$2.52 +0.03 (+1.41%) As of 05:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Cycurion reported Q1 2025 earnings on June 5, 2025. The company reported EPS of -$134.40, while revenue was $3.87 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateJune 5, 2025TimeAfter Market ClosesConference Call DateJune 6, 2025Conference Call7:00 AM ET Cycurion EPS ResultsActual EPS-$134.40Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ACycurion Revenue ResultsActual Revenue$3.87 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(8-K)Quarterly Report(10-Q) Cycurion Q1 2025 Earnings FAQ Did Cycurion beat earnings estimates for Q1 2025? Cycurion (NASDAQ:CYCU) reported earnings of -$134.40 per share for Q1 2025. The report was announced on Thursday, June 5, 2025. What was Cycurion's revenue for Q1 2025? Cycurion reported revenue of $3.87 million for Q1 2025. Cycurion Earnings HeadlinesCycurion Relaunches as a Predictive Cybersecurity Company, Powered by AI and Led by Former Intelligence Community and Private-Sector Cyber ExpertsOctober 14 at 8:20 AM | globenewswire.comExclusive Interview with Cycurion (Nasdaq: CYCU) CEO L. Kevin Kelly Discussing the Company's Largest Contract Award and Expansion of Its Diversified Cybersecurity Growth ...October 13 at 1:21 PM | markets.businessinsider.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.October 15 at 1:00 AM | Weiss Ratings (Ad)Exclusive Interview with Cycurion (Nasdaq: CYCU) CEO L. Kevin Kelly Discussing the Company's Largest Contract Award and Expansion of Its Diversified Cybersecurity Growth StrategyOctober 13 at 8:00 AM | globenewswire.comFinancial Contrast: Amadeus IT Group (OTCMKTS:AMADY) vs. Cycurion (NASDAQ:CYCU)October 7, 2026 | americanbankingnews.comCycurion Shares Rise After Regaining Compliance With Listing RuleOctober 3, 2026 | marketscreener.comMSee More Cycurion Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cycurion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cycurion and other key companies, straight to your email. Email Address About CycurionCycurion (NASDAQ:CYCU) is a healthcare technology and services company that helps health plans, government healthcare programs and other organizations improve member engagement, care coordination and operational efficiency. The company combines technology with business-process services to support healthcare administration and delivery. Its solutions are designed to address areas such as member communications, customer service, care management and payment or claims-related processes. By helping healthcare organizations interact with members and manage administrative workflows, Cycurion seeks to improve service quality while supporting better outcomes and cost control. Cycurion became a publicly traded company on the Nasdaq under the symbol CYCU following a business combination involving Western Acquisition Ventures Corp. Publicly available information indicates that its primary focus is the U.S. healthcare market, particularly government-sponsored and commercial healthcare programs. Information about the company's historical operations and leadership is limited.View Cycurion ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.